Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04959929 · ClinicalTrials.gov registry record · NA

Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy

A NA study of Chemotherapy-induced Peripheral Neuropathy, sponsored by University of Oklahoma.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04959929 is a NA study of Chemotherapy-induced Peripheral Neuropathy that is active but no longer recruiting, run by University of Oklahoma. The registered enrollment target is 15 participants, below the 138-participant average among 29 other Chemotherapy-induced Peripheral Neuropathy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04959929, a NA study of Chemotherapy-induced Peripheral Neuropathy, is active but no longer recruiting, sponsored by University of Oklahoma.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This study will perform an early Phase I feasibility study with single-arm, double-baseline repeated measured design. The investigators will test the feasibility of using focal vibration to improve symptoms of persistent CIPN.

Conditions Studied

Chemotherapy-induced Peripheral Neuropathy

Interventions

  • DEVICE Focal vibration therapy

Study Locations (1)

Oklahoma

  • Stephenson Cancer Center, OU Health - Oklahoma City

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-02-09
Est. Completion 2025-07-01
Phase NA

Sponsor

University of Oklahoma

358 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04959929

The ClinicalTrials.gov registry entry for NCT04959929 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 138-participant average among 29 other Chemotherapy-induced Peripheral Neuropathy trials with a reported enrollment target (89% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chemotherapy-induced Peripheral Neuropathy appearing as the primary indexed condition, and to 1 intervention - of which Focal vibration therapy is the first listed.

NCT04959929 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT04959929 about?

NCT04959929 is a clinical study titled "Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy". This study will perform an early Phase I feasibility study with single-arm, double-baseline repeated measured design. The investigators will test the feasibility of using focal vibration to improve symptoms of persistent CIPN.

What is the current status of trial NCT04959929?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2023-02-09. Estimated completion is 2025-07-01.

What conditions does trial NCT04959929 study?

This clinical trial studies the following conditions: Chemotherapy-induced Peripheral Neuropathy.

What interventions are being tested in trial NCT04959929?

The interventions under investigation include: Focal vibration therapy (DEVICE).

Who is sponsoring clinical trial NCT04959929?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04959929 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chemotherapy-induced Peripheral Neuropathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chemotherapy-induced Peripheral Neuropathy

All registered trials for this condition

Oklahoma

All trials with a study site in Oklahoma

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.